Stock screenerAll disclosures →
EDGAR →
NRC
Conviction 75HealthcareScan · Thu, Jun 25, 2026NRC$20.52-0.87%
ResistanceSupportVol 14Vol MA14 184.37K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price20.52
Change-0.87%
Gap-1.21%
Rel volume0.34×
Avg volume170.58K
Avg $ vol3.36M
SMA 2019.44
SMA 5018.67
SMA 20016.65
Price vs 50+9.92%
Price vs 200+23.25%
MA stackbullish
50/200 cross—
Supertrendup · 17.61
RSI (14)59
MACD hist0.10
MACD crossbull · 1d
Stoch %K / %D77 / 74
ADX (14)12
+DI / −DI23 / 16
RSI divergenceBearish
MACD divergenceBearish
ATR %+5.30%
ADR %5.95%
52w high22.48
52w low11.42
From 52w high-8.72%
Above 52w low+79.68%
New 52w highNo
SqueezeOff
Bollinger width17.48%
%B0.82
Donchian pos76.78%
Donchian high21.48
Donchian low17.35
AVWAP (52w high)17.48
vs AVWAP high+17.38%
AVWAP (52w low)17.01
vs AVWAP low+20.63%
OBV trendUp
Chaikin MF (20)0.24
Today vs 20d0.34×
Avg vol (14d)184.37K
Avg vol (20d)170.58K
Avg $ vol (20d)3.36M
Market cap462.45M
RS 3m (vs SPY)+6.44%
RS 6m (vs SPY)+2.96%
RS line new highNo
Trend template8/8
Technical rank79.0
1 week+15.61%
1 month+7.77%
3 months+19.44%
6 months+8.69%
1 year+19.03%
YTD+13.81%
P/E15.39
P/B34.27
P/S3.37
P/FCF29.37
EPS50.00
Div yield2.37%
ROE222.65%
ROA22.33%
Debt/Eq5.56
Current0.52
EV/EBITDA20.27
Gross margin—
Net margin21.87%
Rev growth-3.96%
EPS growth30.96%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value534.99M
Revenue34.8M
Net income6.99M
Gross profit—
Free cash flow15.74M
IndustrySERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
ExchangeNasdaq
Shares out—
Employees357
ListedFri, Oct 10, 1997
Free float11.46M
Float %50.6%
Short interest466.58K
Days to cover4.6d
Short volume29.6%
Squeeze score31 / 100
Next earningsMon, Jul 27, 2026 (32d)
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA
Conviction75 / 100
Pattern quality—
Tech rank79.0 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance21.00
Support17.48
Days since event—
Candle confirm—
News sentiment—
Financials as of Sun, Sep 30, 2018 · quarterly.
Congress activity
Disclosed STOCK Act trades in NRC
No recent disclosed trades by Congress in NRC. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in NRC · 5 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Lockhart Stephen H Director · Common Stock · 2026-06-23 | Grant | 7.7K | — | 2026-06-23 | 2026-06-25 |
Berwick Donald M Director · Common Stock · 2026-06-23 | Grant | 7.7K | — | 2026-06-23 | 2026-06-25 |
Wheeler Penny Ann Director · Common Stock · 2026-06-23 | Grant | 7.7K | — | 2026-06-23 | 2026-06-25 |
Bhandari Parul Director · Common Stock · 2026-06-23 | Grant | 7.7K | — | 2026-06-23 | 2026-06-25 |
NUNNELLY JOHN N Director · Common Stock · 2026-06-23 | Grant | 7.7K | — | 2026-06-23 | 2026-06-25 |
SEC filings
EDGAR filings in NRC · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.